Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

27277studies shown

Showing 8,377-8,388 of 27,277

CompletedNCT00001658

Amoxicillin for children with sudden OCD or tic symptoms after strep infection

About this title

Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections

Read the official source — NCT00001658

Official study title

A Placebo Controlled Trial of Amoxicillin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections

This study has finished and is no longer accepting participants.

In Bethesda

OCDMedication study

Countries: United States
Sponsor: National Institute of Mental Health (NIMH) (Government agency)

View study

Active Not RecruitingNCT05905003

Predicting outcomes for people at clinical high risk of psychosis

About this title

AMP SCZ® Observational Study: PREDICT-DPACC

Read the official source — NCT05905003

Official study title

Accelerating Medicines Partnership® Schizophrenia Observational Study: Psychosis Risk Evaluation, Data Integration, and Computational Technologies -Data Processing, Analysis, and Coordination Center and Coordination Center

This study is no longer accepting new participants.

Multiple locations, including Irvine

SchizophreniaObservational studyAges 12–30

Countries: United States, Australia, Canada, + 10 others
Sponsor: Brigham and Women's Hospital

View study

CompletedNCT04027361

Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)

Official study title

Driving Performance in Patients Aged 18 to 25 Years With Attention-Deficit/Hyperactivity Disorder (ADHD) After a Single-Dose of Amphetamine Extended-Release Tablets: A Pilot, Double-Blind, Placebo-Controlled Study

This study has finished and is no longer accepting participants.

In Boston

ADHDMedication studyAges 18–25

Countries: United States
Sponsor: Tris Pharma, Inc.

View study

CompletedNCT03834766

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD

This study has finished and is no longer accepting participants.

Multiple locations, including Bradenton

ADHDMedication studyAges 18–60

Countries: United States
Sponsor: Tris Pharma, Inc.

View study

SuspendedNCT04934553

Amplification of Positivity for Addiction Co-Occurring With Anxiety or Depression

Official study title

Amplification of Positivity for Alcohol Use Disorder (AMP-A): Feasibility and Pilot Study

Recruitment is currently suspended.

Multiple locations, including La Jolla

Depression, Addiction, ...Behavioural studyAges 18–55

Countries: United States
Sponsor: Charles Taylor

View study

Active Not RecruitingNCT06030154

Amplification of Positivity for Alcohol Use

Official study title

Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder With Anxiety or Depression

This study is no longer accepting new participants.

In Tulsa

Addiction, Depression, ...Behavioural studyAges 18–65

Countries: United States
Sponsor: Laureate Institute for Brain Research, Inc.

View study

UnknownNCT06452849

Amygdala and dLPFC MRI-TIS for Depression in Adolescents

Official study title

Temporal Interference Stimulation of Amygdala and dLPFC: A Randomized Controlled Trial for Adolescent Depression

Current recruitment status is unconfirmed.

In Shanghai

DepressionDevice studyAges 14–18

Countries: China
Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University

View study

UnknownNCT06461260

Amygdala MRI-TIS for Depression

Official study title

Safety, Efficacy and Neuroimaging Mechanisms of Amygdala Temporal Interference Stimulation Therapy for Depression

Current recruitment status is unconfirmed.

In Shanghai

DepressionDevice studyAges 18–65

Countries: China
Sponsor: Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University

View study

CompletedNCT06477276

Amygdala TIS for Depression

Official study title

A Multicenter, Randomized, Controlled, Double-Blind Trial on the Efficacy and Safety of Amygdala Temporal Interference Stimulation for the Treatment of Depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Shanghai

DepressionDevice studyAges 18–65

Countries: China
Sponsor: Ruijin Hospital

View study

CompletedEUCTR 2009-018064-95

Amyloid imaging in late life depression

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium

DepressionHistorical research record

Countries: Belgium
Sponsor: University of Leuven

View study

CompletedNCT03329677

An 18-Month Psychotherapy of Borderline Personality Disorder

This study has finished and is no longer accepting participants.

In New York

Personality disordersInterventional studyAges 18–35

Countries: United States
Sponsor: Weill Medical College of Cornell University

View study

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.